Developing Novel Solutions for ADPKD: An Interview with XORTX Therapeutics’ CEO Dr. Allen Davidoff
Source: Pixabay.com

Developing Novel Solutions for ADPKD: An Interview with XORTX Therapeutics’ CEO Dr. Allen Davidoff

There are limited therapeutic options for people living with autosomal dominant polycystic kidney disease (ADPKD); currently, the only real standards-of-care include dialysis and kidney transplantation. When discussing the therapeutic landscape,…

Continue Reading Developing Novel Solutions for ADPKD: An Interview with XORTX Therapeutics’ CEO Dr. Allen Davidoff
FDA Rejects CKD Drug Tenapanor
Photo by Paweł Czerwiński on Unsplash

FDA Rejects CKD Drug Tenapanor

Despite drug developers' best efforts, the path to approval is not always easy. Ask biotechnology company Ardelyx, whose potential treatment option tenapanor was recently rejected by the FDA. According to…

Continue Reading FDA Rejects CKD Drug Tenapanor
CDI Startup Aims to Address Hydrocephalus
source: pixabay.com

CDI Startup Aims to Address Hydrocephalus

Normally, cerebrospinal fluid (CSF) surrounds our brain and spinal cord, providing numerous benefits from injury protection and nutrient delivery to waste removal. Hydrocephalus, or "water on the brain," occurs when…

Continue Reading CDI Startup Aims to Address Hydrocephalus
New Method Easily Distinguishes Between Multiple Sclerosis and Neuromyelitis Optica
Science!

New Method Easily Distinguishes Between Multiple Sclerosis and Neuromyelitis Optica

  Technological advancement throughout the world will ultimately lead to new ideas and strategies within the medical realm. As reported by Azo Sensors, a team of Brazilian researchers is already…

Continue Reading New Method Easily Distinguishes Between Multiple Sclerosis and Neuromyelitis Optica
Israeli Placenta-based Cell Therapy for COVID-19 Moved into Clinical Trial
source: pixabay.com

Israeli Placenta-based Cell Therapy for COVID-19 Moved into Clinical Trial

As originally shared in Tech Startups, an Israeli biotech company called Pluristem has created a placenta-based cell therapy to treat patients with COVID-19. So far, the therapy, which uses PLacental…

Continue Reading Israeli Placenta-based Cell Therapy for COVID-19 Moved into Clinical Trial
Faulty Proteins and Failed Genes: Understanding the Biology Behind Congenital Diseases
source: pixabay.com

Faulty Proteins and Failed Genes: Understanding the Biology Behind Congenital Diseases

Patients with congenital diseases often experience a range of uncomfortable symptoms. On one side of the world, a family with erythromelalgia, a painful condition which can cause redness and swelling…

Continue Reading Faulty Proteins and Failed Genes: Understanding the Biology Behind Congenital Diseases